Transmission of hepatitis C virus in Asia: past and present perspectives.
about
Treatment of Hepatitis C Virus Infection in Children Less than 12 Years of Age in Developing CountriesManaging Occupational Risks for Hepatitis C Transmission in the Health Care SettingThe epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analysesHepatitis D virus genotypes in intravenous drug users in taiwan: decreasing prevalence and lack of correlation with hepatitis B virus genotypes.Hidden hazards of HCV transmission.Recent updates in hepatitis vaccination and the prevention of hepatocellular carcinoma.Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy.Health care-associated hepatitis C virus infection.Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients.Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular CarcinomaChanging disease burden of hepatocellular carcinoma in the Far East and Southeast Asia.Hepatitis B and C virus prevalence in a rural area of South Korea: the role of acupunctureClinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6Acute hepatitis C: a systematic review.An overview about hepatitis C: a devastating virus.Genomic variation-guided management in chronic hepatitis C.APASL consensus statements and management algorithms for hepatitis C virus infection.Management of hepatitis C patients with decompensated liver disease.The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.Less-established risk factors are common in Asian Americans with hepatitis C virus: a case-controlled study.Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.Sustained viral response and hematological adverse events during chronic hepatitis C infection treatment.Knowledge about hepatitis and previous exposure to hepatitis viruses in immigrants and refugees from the Mekong Region.Outcomes of HCV treatment: who does well and who does not?Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother.JGH and Asia-Pacific consensus on prevention and management of gastrointestinal and liver diseases.Hepatitis C virus and lipid profiles: more questions than answers?Public health challenges in hepatitis C virus infection.Ethnic and cultural determinants influence risk assessment for hepatitis C acquisition.Evaluation of three techniques for detection of IL28B SNP: A prognostic tool for HCV treatment outcome.
P2860
Q26781890-7AFB08AA-2103-44AD-9005-24D650047225Q27477626-8FEEAF08-3D0D-4C89-B87D-20F0E5164BFDQ28087794-4C8DA5B1-2C20-46B6-8C66-F04039ABDACBQ33965808-4150DCA4-0206-45B4-8EED-BB2E5C00C74BQ34114816-82914CAF-3795-4164-8AC6-D191805838D7Q34483036-22A3BB5C-F135-4419-8247-EC6DBE23FC59Q34621423-DFA26935-0D9B-4212-B97F-0F1B57AA9917Q34696503-287A4725-0B24-4FCC-8B29-ED8122A4C062Q34876460-8DF230CF-5B86-47E2-A536-A817D074D016Q35040102-974BD499-81AA-428E-960F-91D17D7EA785Q35595548-FC25682F-4158-466F-A009-9B6EFE24B4DDQ36184218-657B3289-6AC6-459B-924A-269B93A8843FQ36623986-3C8BC569-19E4-4D2E-8AD0-B4A2736D6365Q36756371-DC258977-36A3-4625-B427-0BB67D174D09Q37162708-9B551892-45CB-4D23-AF8B-50228A1EE516Q37719516-99C89C87-10CA-4E1F-A817-EF78CD5204D4Q38038693-574FED9D-B68C-4C1B-BF93-B15D543B8A23Q38552131-C990859C-8AFE-4837-AFDD-7EC1EB3A8530Q38702156-6BFA7F47-14CF-4080-8E05-B79DE6EAD9B1Q41467901-707A1C0A-E4E7-4126-8F1F-9FCFAAF3B03AQ42265655-9EF1B3FA-CD16-47B6-8557-A27734FAC7D5Q42288046-54FCE46A-D9AC-4F05-9795-0783412CD623Q42554331-BB2E486A-E176-4E19-A41A-93DFD8DB1D16Q42991433-995724E8-047B-4BB3-A11D-1CA831F223C3Q42997690-3A59723B-68C6-4A1F-B6D0-B5BCB67CD170Q42997700-47C215E6-B17B-40E9-8385-33AE18E31058Q43651135-1B7BAA0D-1274-4E58-9308-D2291D1013B0Q43879413-556CFA56-3AE6-413B-B84B-4B6DA60CBA3DQ44983621-7DC0A6AB-BBFB-406F-8014-97DB0F1C90A2Q45741259-CCA796ED-82C8-4432-BD17-B6D254459141Q47333581-B5AC9ED9-7972-4E49-B090-166749586FFDQ48286494-6D406ABA-795D-402B-AFD9-CA92A87078FE
P2860
Transmission of hepatitis C virus in Asia: past and present perspectives.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Transmission of hepatitis C virus in Asia: past and present perspectives.
@ast
Transmission of hepatitis C virus in Asia: past and present perspectives.
@en
type
label
Transmission of hepatitis C virus in Asia: past and present perspectives.
@ast
Transmission of hepatitis C virus in Asia: past and present perspectives.
@en
prefLabel
Transmission of hepatitis C virus in Asia: past and present perspectives.
@ast
Transmission of hepatitis C virus in Asia: past and present perspectives.
@en
P2860
P1476
Transmission of hepatitis C virus in Asia: past and present perspectives.
@en
P2860
P356
10.1046/J.1440-1746.2000.02108.X
P478
P577
2000-05-01T00:00:00Z